These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Neuroendocrine assessment of serotonin (5-HT) function in chronic fatigue syndrome. Yatham LN; Morehouse RL; Chisholm BT; Haase DA; MacDonald DD; Marrie TJ Can J Psychiatry; 1995 Mar; 40(2):93-6. PubMed ID: 7788624 [TBL] [Abstract][Full Text] [Related]
26. Association of T and NK Cell Phenotype With the Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Rivas JL; Palencia T; Fernández G; García M Front Immunol; 2018; 9():1028. PubMed ID: 29867995 [TBL] [Abstract][Full Text] [Related]
27. [Reaction on 'Chronic fatigue syndrome: a psychoneuroimmunological perspective' (1)]. Maes M; Twisk FN Tijdschr Psychiatr; 2009; 51(10):783-4; author reply 784-6. PubMed ID: 19821247 [No Abstract] [Full Text] [Related]
28. Predictors of persistent and new-onset fatigue in adolescent girls. ter Wolbeek M; van Doornen LJ; Kavelaars A; Heijnen CJ Pediatrics; 2008 Mar; 121(3):e449-57. PubMed ID: 18310166 [TBL] [Abstract][Full Text] [Related]
29. Chronic fatigue syndrome. Recent advances in diagnosis and treatment. Bell DS Postgrad Med; 1992 May; 91(6):245-52. PubMed ID: 1579531 [TBL] [Abstract][Full Text] [Related]
31. The effects of a laboratory stressor on natural killer cell function in chronic fatigue syndrome patients. Wemm KM; Trestman RL Psychosomatics; 1991; 32(4):470-1. PubMed ID: 1961870 [No Abstract] [Full Text] [Related]
32. [Reaction on 'Chronic fatigue syndrome: a psychoneuroimmunological perspective' (2)]. Den Broeder G; Arnoldus R Tijdschr Psychiatr; 2009; 51(10):786-7; author reply 787-8. PubMed ID: 19821248 [No Abstract] [Full Text] [Related]
33. Immunologic parameters in chronic fatigue syndrome, major depression, and multiple sclerosis. Natelson BH; LaManca JJ; Denny TN; Vladutiu A; Oleske J; Hill N; Bergen MT; Korn L; Hay J Am J Med; 1998 Sep; 105(3A):43S-49S. PubMed ID: 9790481 [TBL] [Abstract][Full Text] [Related]
34. Social support and the persistence of complaints in chronic fatigue syndrome. Prins JB; Bos E; Huibers MJ; Servaes P; van der Werf SP; van der Meer JW; Bleijenberg G Psychother Psychosom; 2004; 73(3):174-82. PubMed ID: 15031590 [TBL] [Abstract][Full Text] [Related]
35. Immunological and psychological dysfunction in patients receiving immunotherapy for chronic fatigue syndrome. Hickie I; Lloyd A; Wakefield D Aust N Z J Psychiatry; 1992 Jun; 26(2):249-56. PubMed ID: 1642616 [TBL] [Abstract][Full Text] [Related]
36. Cytokine inhibition in chronic fatigue syndrome patients: study protocol for a randomized controlled trial. Roerink ME; Knoop H; Bredie SJ; Heijnen M; Joosten LA; Netea MG; Dinarello CA; van der Meer JW Trials; 2015 Oct; 16():439. PubMed ID: 26438161 [TBL] [Abstract][Full Text] [Related]
37. Seasonal symptom variation in patients with chronic fatigue: comparison with major mood disorders. Zubieta JK; Engleberg NC; Yargiç LI; Pande AC; Demitrack MA J Psychiatr Res; 1994; 28(1):13-22. PubMed ID: 8064638 [TBL] [Abstract][Full Text] [Related]
38. Is a diagnostic blood test for chronic fatigue syndrome on the horizon? Maes M; Rodriguez LA; Morris G Expert Rev Mol Diagn; 2019 Dec; 19(12):1049-1051. PubMed ID: 31617771 [No Abstract] [Full Text] [Related]